Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor

NCT05933668 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
11
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University

Collaborators